Inhibition of IRP2-dependent reprogramming of iron metabolism suppresses tumor growth in colorectal cancerCELL COMMUNICATION AND SIGNALINGIF8.92024-10-070OAAI
Inhibition of IRP2-dependent reprogramming of iron metabolism suppresses tumor growth in colorectal cancerCELL COMMUNICATION AND SIGNALINGIF8.92024-08-233OAAI
KS20226, a first-in-class IRP2 inhibitor, preferentially induces reprogramming of iron metabolism and suppresses tumor growth in colorectal cancerCANCER RESEARCHIF16.62024-03-220PRE
KS10076, a chelator for redox-active metal ions, induces ROS-mediated STAT3 degradation in autophagic cell death and eliminates ALDH1+ stem cellsCELL REPORTSIF6.92022-07-0111OAAI